[1]张璇,徐晶钰,秦志丰,等.从痰论治胃癌前病变临证思路[J].中国中医药信息杂志,2014,21(3):99-100.[doi:10.3969/j.issn.1005-5304.2014.03.033]
 [J].zhongguo zhongyiyao xinxi zazhi,2014,21(3):99-100.[doi:10.3969/j.issn.1005-5304.2014.03.033]
点击复制

从痰论治胃癌前病变临证思路

参考文献/References:

 [1] 张声生,牧童.慢性萎缩性胃炎癌前病变中医药防治研究进展[J].中西医结合消化杂志,2004,12(6):376-378.

[2] Gao QY, Wang ZH, Chooi EY, et al. A novel model might predict the risk of chronic atrophic gastritis:a multicenter prospective study in China[J]. Scand J Gastroenterol,2012,47(5):509-517.

[3] 王璐林,吴鹏.谈慢性萎缩性胃炎癌前病变的中医治疗[J].新疆中医药,2003,21(5):4-5.

[4] 胡玲,劳绍贤,陈蔚文,等.胃癌癌前病变治疗研究的思路[J].中国中西医结合杂志,1999,19(6):372.

[5] 修丽娟,魏品康,秦志丰,等.胃癌复发从痰论治理论探析[J].中国中西医结合消化杂志,2012,20(11):512-514.

[6] 许玲,陈亚琳,刘咏英,等.金龙蛇口服液合华蟾素注射液、黄芪注射液治疗Ⅳ期胃癌的临床观察[J].成都中医药大学学报,2005,28(1):7-9.

[7] 桂牧微,魏品康,陆烨,等.消痰散结方药物血清对人胃癌MKN-45细胞增殖和凋亡的影响[J].中西医结合学报,2010,8(3):250-251.

[8] 庞斌,魏品康,毛竹君,等.消痰散结方对裸鼠MKN-45人胃癌组织中血管内皮生长因子D表达的影响[J].中国中医药信息杂志,2011,18(8):42-44.

[9] 余志红,赵颖,胡仙珍,等.消痰散结方对荷瘤裸鼠胃癌组织中成纤维细胞活化蛋白表达的影响[J].中华中医药学刊,2010,28(2):331-334.

[10] 巨大维,魏品康,孙大志,等.消痰散结方对鼠胃移植瘤相关炎性因子表达的影响[J].中国中医急症,2011,20(3):407-409.

相似文献/References:

[1]徐晶钰,张璇,魏品康.中医药治疗湿疹合并抑郁症思路[J].中国中医药信息杂志,2011,18(10):95.[doi:10.3969/j.issn.1005-5304.2011.10.047]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(3):95.[doi:10.3969/j.issn.1005-5304.2011.10.047]
[2]颜兵,秦志丰,魏品康.中医“痰”学说与胃癌干细胞[J].中国中医药信息杂志,2012,19(7):93.[doi:10.3969/j.issn.1005-5304.2012.07.045]
 [J].zhongguo zhongyiyao xinxi zazhi,2012,19(3):93.[doi:10.3969/j.issn.1005-5304.2012.07.045]
[3]王志坤,刘启泉,李博林,等.小归芍化浊解毒方对胃癌前病变大鼠表皮生长因子受体及血管内皮生长因子表达的影响[J].中国中医药信息杂志,2012,19(12):34.[doi:10.3969/j.issn.1005-5304.2012.12.013]
 WANG Zhi-kun,LIU Qi-quan,LI Bo-lin,et al.Effect of Eliminate Turbid Fluid and Remove Toxicity of Xiaoguishao on EGFR and VEGF in Rats with Gastric Carcinoma Precancerosis[J].zhongguo zhongyiyao xinxi zazhi,2012,19(3):34.[doi:10.3969/j.issn.1005-5304.2012.12.013]
[4]孙大志,巨大维.魏品康从痰论治顽固复发性天疱疮验案[J].中国中医药信息杂志,2010,17(8):77.[doi:10.3969/j.issn.1005-5304.2010.08.043]
[5]王学好. 疏肝和胃方治疗胃癌前病变疗效观察[J].中国中医药信息杂志,2012,19(4):83.[doi:10.3969/j.issn.1005-5304.2012.04.037]
 [J].zhongguo zhongyiyao xinxi zazhi,2012,19(3):83.[doi:10.3969/j.issn.1005-5304.2012.04.037]
[6]张婧延,才博华,姜之炎.中医从痰论治儿童腺样体肥大概况[J].中国中医药信息杂志,2015,22(6):134.[doi:10.3969/j.issn.1005-5304.2015.06.043]
 ZHANG Jing-yan,CAI Bo-hua,JIANG Zhi-yan.Overview of Treating Pediatric Adenoid Hypertrophy from Phlegm of Traditional Chinese Medicine[J].zhongguo zhongyiyao xinxi zazhi,2015,22(3):134.[doi:10.3969/j.issn.1005-5304.2015.06.043]
[7]黄铭涵,黄健,李思汉,等.复方胃炎合剂逆转胃癌前病变的临床研究[J].中国中医药信息杂志,2016,23(4):20.[doi:10.3969/j.issn.1005-5304.2016.04.006]
 HUANG Ming-han,HUANG Jian,LI Si-han,et al.Clinical Research on Reversion of Precancerous Lesions of Gastric Carcinoma by Compound Gastritis Mixture[J].zhongguo zhongyiyao xinxi zazhi,2016,23(3):20.[doi:10.3969/j.issn.1005-5304.2016.04.006]
[8]张璇,徐晶钰,孙大志,等.消痰和胃方对胃癌前病变大鼠细胞凋亡的影响[J].中国中医药信息杂志,2017,24(4):54.[doi:10.3969/j.issn.1005-5304.2017.04.014]
 ZHANG Xuan,XU Jing-yu,SUN Da-zhi,et al.Effects of Xiaotan Hewei Formula on Cell Apoptosis of Precancerous Lesions of Gastric Carcinoma Rats[J].zhongguo zhongyiyao xinxi zazhi,2017,24(3):54.[doi:10.3969/j.issn.1005-5304.2017.04.014]
[9]赵颖,修丽娟,王晓炜,等.魏品康从痰论治胃癌学术思想初探[J].中国中医药信息杂志,2017,24(5):106.[doi:10.3969/j.issn.1005-5304.2017.05.025]
 ZHAO Ying,XIU Li-juan,WANG Xiao-wei,et al.Discussion on Academic Ideas of WEI Pin-kang in Treating Gastric Carcinoma Based on the Phlegm Theory[J].zhongguo zhongyiyao xinxi zazhi,2017,24(3):106.[doi:10.3969/j.issn.1005-5304.2017.05.025]
[10]汪小敏,曹林忠,宋敏,等.从痰论治激素性股骨头坏死OPG/RANK/RANKL信号调控机制研究进展[J].中国中医药信息杂志,2017,24(10):133.[doi:10.3969/j.issn.1005-5304.2017.10.036]
 WANG Xiao-min,CAO Lin-zhong,SONG Min,et al.Research Progress in OPG/RANK/RANKL Signal-regulated Mechanism of Steroid Induced Avascular Necrosis of Femoral Head from Phlegm Theory[J].zhongguo zhongyiyao xinxi zazhi,2017,24(3):133.[doi:10.3969/j.issn.1005-5304.2017.10.036]

备注/Memo

基金项目:国家自然科学基金(81202678);上海市中医药事业发展三年行动计划(ZYSNXD-CC-ZDYJ024);第二军医大学青年启动基金(2012QN17)

更新日期/Last Update: